Explore the full record of transactions filed by Jiang Wenbin. Director active across 1 companies, notably Cytek Biosciences, Inc.. Aggregated, 9 reports have been published. Total volume traded: €547k. The latest transaction was disclosed on 7 June 2022 — Cession. Regulator: SEC (Form 4). The full history is free.